A customer reported a positive result with a cyclesure® 24 biological indicator (bi) after a completed sterrad® cycle.The affected load was released and used on a patient.There was no report of infection, injury or harm to patient(s) associated with this issue.Although there is no report of patient injury or harm and no prior incidents have resulted in serious injury, advanced sterilization products (asp) has determined in this situation sterility cannot be assured.Therefore, as a matter of policy asp had decided to report all incidents of positive cyclesure® 24 biological indicators when the load has been released and used on patient(s) prior to reprocessing.
|
It was initially reported that the load was released and used on a patient; however, the affiliate later confirmed that the load was recalled/reprocessed.H3: asp investigation summary: the investigation included a review of the device history record (dhr), trending of lot number, system risk analysis (sra), visual analysis and retains analysis.Trending analysis by lot number was reviewed from 11/09/2018 to 04/27/2019 and trending was not exceeded.The sra indicates the risk associated with a quality problem with no impact on safety is "low." the single cyclesure® 24 bi was not available for return and visual analysis.Thirty-two retains bis were subject to functional evaluation.All thirty-two bis met specification.The suspect positive bi issue could not be confirmed as the suspect product was not available for return and visual analysis.There is no evidence to suggest an alleged deficiency since the dhr review found no anomalies that would contribute to a positive bi result, retains product met functional specifications and lot history review did not show any significant trend.The issue will continue to be tracked and trended.Asp complaint ref #: (b)(4).
|